Volume 1
International Journal of Infectious Diseases
Author Index
Abbott, Sharon, 212
Ackers, Marta, 2 12
Acosta, Alberto, 2 17
Alano, Filoteo A., 222
Almirante, Benito, 179
Anaissie, Elias, S32
Andriole,Vincent T., S25
Arduino, Sonia, S56
Armstrong, Donald, 2, 18,63, S28
Batungwanayo, Jean, 22
Beenhouwer, David O., 98
Bernard, Edward M., 18, S28
Bock, Hans L., 6
Bodey, Gerald l?, S2
Bogaerts, Hugues, 6
Bogaerts, Joseph, 22
Bowden, Raleigh A., S47
Brown, Sheldon, 192
Bryan, Charles S., 182
Buchanan-Chell, Maureen, 92,202
Cantrill, Herbert L., 70
Capdevila, Jose A., 179
Chang, Hong-Jen, 83
Chang, Kenneth S.S., 83
Chang, Po-Ya, 83
Chanock, Stephen J., S 11, S20
Chauca, Gloria, 75
Chen, Chien-Hsin, 18
Chen. Mao-Yuan. 83
Cheong,Yuet-M&g, 95
Choi, M.Y., 14
Chuang, Che-Yen, 83
Chuang, Elaine L., 70
ChungTRaymond, 2 15
Clemens, Ralf. 6
Clerinx, Jan, 22
Curfs, Jo H.A.J., 206
Currie, Brian l?, 87
Dale, JeremyW, 192
Davis, Roger, 70
de Jesus, Paulo, 28
De Pauw, Ben E., S32
de Quadros, Ciro A., 125
Dictar, Miguel, S56
Eagan, Janet A., 63
Fagundes-Neto, Ulvsses. 65
Femberg, Judith E.: 70
Fessard, Christian. 226
Foncuberta, Cecilia, S56
Forrest, Bruce, 152
Framm, Stuart R., 35
Geddes, Alasdan, 117
Gellin, Bruce, 217
Gershon, Anne A., 130
Gilbert, Holly M., 35
Gnass, Silvia, 87
Gottfarb, Peter, 143
236
Gotuzzo, Eduardo, 37,75
Granoff, Dan M., 152
Greene, Katherine D., 2 12
Hampson, Alan W ,158
Hart, Georgiana, 212
Heinemann, Murk-Hem 70
Herbrecht, Raoul, S42
Ho, Hong-Nerng, 83
Ho, John L., 35
Hoogkamp-Korstanje, Jacomina A.A.,
206
Huang, Shiu-Feng, 83
Hung, Chien-Ching, 83
Hurwitz, Shelley, 70
Ishimaru,Toshiyuki, 78
Jacobs, Jonathan, 217
Jennings, Harold J., 158
Kagame,Abel, 22
Kanna, Manuel, 75
Kasper, Dennis L., 118
Kerr&an, Marv Ellen, 83
Keystone, Jay S., 226
Kirkland.Terri. 92.202
Knuf, Markus, 6 ’
Ko,Ying-Chin, 83
Koenig, Helene, S42
Kunze, Zubair, 192
Kurtz, Jean E., S42
Kusminsky Gustavo, S56
Lagergard,Teresa, 148
Laurence, Jeffrey, 4
Lau,YL., 14
Lee,Adrian, 47
Lee, C.K., 14
Lee, S.S., 14
Letscher,Val&ie, S42
Levi, Michael H., 87
Lin, Chang-Ping, 83
Lin, Rong-Luh, 18
Lin, Ruey-Yi, 83
Lin,Yvonne G., 83
Liquete, Rosemarie R., 222
Louria, Donald B., 59
Maayan, Shlomo, 199
Marks, Nila, 199
McAdam, Keith PWJ., 172
McEvoy, Peter, 2 15
McFadden, Johnjoe, 192
McKenzie, Margaret, 92,202
Meis, Jacques EG.M., 206
Melchers, Willem J.G., 206
Mendoza, Myrna T ,222
Menichetti, Francesco, S52
Mintz, Eric, 212
Morag,Abraham, 199
Morales, Ingrid, 22
Moran, Kimberly, 2 15
Muschenborn, Simone, 6
Neil, Lucien, 199
Niho, Noshiyuki, 78
Nosanchuk, Joshua D., 98
Nur,Yassin A., 186
Odinot, Paul T., 206
Okada, Kaoru, 78
Olin, Patrick, 143,235
Ona, Enrique T., 222
Owens, Susan, 70
Pagaduan, Remedios, 212
Palmblad. Tan. SGO
Pang,Tikki, 95
Patterson,Thomas E, S64
Perez, Manolo Hernandez, 192
Polsky, Bruce, 70
Power, Maureen E, ,70
Prince, Amy, 217
Ramos, Leticia, 217
Rappuoli, Rino, 152
Rasmussen, Finn, 143
Riley, Lee W, 18,28
Robbins, John B., 148
Salgado, Katia, 28
Salisbury, David M., 119
Sands, Michael L., 70
Santana e Sant’anna, Ciria, 28
Sawae,Yoshiro, 78
Scaletsky Isabel, 65
Schmitt, Heinz-J., 6
Schmitz, Lenora Gandolfi, 65
Seas, Carlos, 37
Seigel, Rebecca R., 28
Sepkowitz, Kent A., 57,115,2 33
Shapiro, Mervyn, 199
Shih.Yaw-Tang. 83
Shimono, Nob&&i, 78
Shorr, Andrew E ,2 15
Soave, Rosemary, 217
Snencer, Kim Li. 2 17
Sirauss, Nurit, 199
Sung, Juei-Low, 83
Taelman, Henri, 22
Takaki, Koji, 78
Taranger, John, 148
Tauxe, RobertV, 212
Taylor, Geoffrey D., 92,202
Thompson, Luis, S70
Thong, Kwai-Lin, 95
Tice, Alan D., 102
Todeschini, Giuseppe, S37
Trollfors, Birger, 148
TWLI, Shing-Jer, 83
van Belkum, Alex, 186
VandenBergh, Marjolein EQ., 186
Van Den Eynde, Joseph, 22
Van de Perre, Philippe, 22
Van Deun, Armand, 22
Vargas, Sergio Luis, S70
 Index 237

Verbrugh, HenriA., 186 gastric, 47-53 Flucytosine, S25-S26

Veron, MariaT., S56 Candida, S7-S9 Fruit. sliced. 212-214
Viterbro, Alexander, 199 antigen and antibody, 78-82, Sl l-S17 Fungal infections
in bone marrow transplants, S56-S58 in bone marrow transplant, ~56
Wagner, Sabine, 6 in cancer, S32-S35 emerging pathogens, S42-S45
Waller, Jocelyn, S42 as contaminant, S37-S38 in immunocompromised host,
Walsh,Thomas J., Sl, Sll. S20 in immunocompromised host, S28-S30
Watts, Douglas M., 75 szO-S23,S28%3O,S33-S35, See also Antifungal therapy
Wessels, Michael R., 107 S47-S5O,S52-S54 Fusariosis, S42, S44-S45
Whang-Peng, Jacqueline, 83 molecular diagnosis of, S20-S23 Fusarium, S42, S44-S45
White, Mary H., S7 Candida albicans, S2-S5, S7-S9, S17,
Wiens, Rhoda, 92,202 s39,s43,S47-S48,S5O,S56-S58 Ganciclovir, 70-74
Wilde, Henry, 135 Candida glabrata, S4, S34, S38, S43, GAS. See Group A Streptococcus
Wolitz. Richard. 70 S47-S48 Gastric cancer, 47-53
Wong,‘K.H., 14 Candida krusei, S3,S4,S9, S16,S34,S38, Gastric ulcers, 47-53
S47,S52,S54 Gastroduodenal diseases, 47-53
Yakrus, MitchellA., 192 Candida lusitaniae, S3, S4, S43 GBMI? See Group B meningococcal
Yamamoto,Victor, 75 Candida parapsilosis, S3, S39, S47-S48 polysaccharide (GBMP) vaccines
Yusuf, Mohamed A., 186 Candida trobicalis, S2-S5, S38. S43, Gram-negative bacteremia, 202-205
S47-S48,552 Group A Streptococcus (GAS), 107- 112
Zeide,Yona, 199 Candidiasis Group B meningococcal meningitis,
Zingman, Barry S., 98 in HIV 552, S54 158-163
Zylberman, Marcelo, S56 invasive, 78-82, S7-S9, Sll-S17, Group B meningococcal polysaccharide
S56-S58 (GBMP) vaccines, 158-163
Subject Index in neutropenia, S2-S5, S32-S35,
S52-S54 Haemophilus influenzae, 179
ABLC. See Amphotericin B lipid com- nosocomial, Sl, S37-S40 Haemophilus infuenzae, type B
plex Children vaccine,7,143,152-153,235
Acquired immunodeficiency syndrome. diarrhea in, 28-34 HAV See Hepatitis A virus
See AIDS meningococcal polysaccharide HBV See Hepatitis B virus
Acute purulent meningitis, 179-180 vaccines in infants and toddlers, Health care workers
Adolescents, 132 153-154 hepatitis and, 230
AIDS (acquired immunodeficiency variceIIa vaccine and, 132-133 Staphylococcus aureus in, 186- 190
syndrome) Cholera Helicobacter&ylori, 47-53
cytomegalovirus retinitis in, 70-74 antimicrobials for, 42-43 Hepatitis A virus (HAV), 226-231
Mycobacterium avium in, 192-198 epidemics, 37-44 Hepatitis B virus (HBV), 226-231
surviving, 4-5 in Latin America, 38-40 Hib vaccine. See Haemophilus
See also HIV prevention of, 43-44 influenzae type B vaccine
Amphotericin B, S2-S5, S25, S28-S29, sliced fruit and, 212-214 HIV (human immunodeficiency virus)
S33,S34,S38,S49,S53,S56-S58 in Zaire, 41 bacterial infection and, 199-200
Amphotericin B lipid complex (ABLC), Cirrhosis, 98-100 candidiasis in, S52, S54
S4,S4O,S42-S45,S49 Clotrimazole, ~26 cryptosporidiosis in, 217-220
Antibiograms, 95-97 CMV See Cytomegalovirus in Hong Kong. 14-16
Antibiotic therapy, 102-106 Cryptococcosis, S28-S30 in neonates, 83-86
Antibodies, 78-82, Sl l-S17 Cryptococcus neoformans, 98-100 nonprogressors of, 14-16
Antifungal therapy, S24-S25, S33, Cryptosporidiosis, 217-220 tuberculosis and, 22-27,173
s37-s40 Cytomegalovirus (CMV), 70-74 See also AIDS
Antigens Hong Kong,HIV in, 14-16
Candida, 78-82, Sll-S17 D-arabinitoI, Sl6-S17 Household communicable diseases,
HSP-90related, Sl6 DEC. See Diethylcarbamazine 233-234
Mycobacterium tuberculosis, Diarrhea HSP-90-related antigen, ~16
176-177 in Brasilia (Brazil), 65-69 HTLV-I. See HumanTcell lymphotropic
Antimicrobials, 42-43 from enterotoxigenic E. coli, 29,33, virus type I
Antirabies sera, 138 65-69 Human immunodeficiency virus. See
Aspergillus, S25, S30, S33, S34, S42, S49, in Salvador (Brazil), 28-34 HIV
S50 Diethylcarbamazine (DEC), 35-36 Human T-cell lymphotropic virus type I
Attenuated varicella vaccine, 130- 133 Diphtheria vaccine. See DTP OILIV-I), 75-77
Azoles, S26, S28 Dogs, 136 HyaIuronic acid, 1 1 1 - 112
Drug users, 229-230
BaciUe Calmette-Guerin (BCG), 172-177 DTP (diphtheria, tetanus, pertussis) Immune globulins, 138
Bacteremia vaccine,6-12,143-147,148-151,235 Immunization
in immunocompetent host, 215-216 economics of, 168
nosocomial, 182-183,202-205 E. coli. See Enterotoxigenic E. coli; future issues, 122-123
Bacterial infection, 199-200 Escherichia coli influenza, 165-169
Bacterial vaccines, 172-177 Emerging fungal pathogens, S42-S45 pneumococcal infections, 165-169
BCG. See BaciIle Calmette-Guerin Encephalitis, 35-36 practice of, 120-122
Blood culture surveillance, 182-185 Enterococcus faecium, 63-64 theory of, 119-120
Bone marrow transplants, S56-S58 Enterotoxigenic E. coli (ETEC), 29,33, See also Vaccines
Bordetellapertus&7, ld, 12 65-69 Immunocompetent host, 215-216
Brasilia (Brazil>, diarrhea in, 65-69 Eschericbia coli, 28-34 Immunocompromised host
Brugia malayi, 35 ETEC. See Enterotoxigenic E. coli Candida in. S20-S23. S28-S30.
S33-S35,'S47-SSd,i52-S$4
Cancer Fluconazole, S2-S5, S26, S33, S47-S48, fungal infections in, S28-S30
candidiasis and, S32-S35 S49-S5O,S52,S53,S56 Infants, 154
238 International Journal of Infectious Diseases / Volume 1, Number 4, April 1997

See also Neonates NPr GBMF! See N-propionylated GBMP Staphylococcus aureus, 186- 190
Infections N-propionylated GBMP (NPr GBMP), Streptococcus, 107- 112
bacterial, 199-200 158-163 Streptococcuspneumoniae, 179-180
pneumococcal, 165-169 Nystatin, S25
renal, 222-225 Taiwan, tuberculosis in, 18-21
societal variables of re-emerging, TB. See.Tuberculosis
59-61 Oka strain varicella-zoster virus, Tetanus vaccine. 6-12.143-147.
transplant, 222-225, S54 130-131 148-151 ’
urinary tract, 92-94 Onchocerca volvulus, 35 Toddlers, 153-154
See also Fungal infections; specific Organ transplants, 222-225, S54 Torulopsis glabrata, S52, S54
infections Outpatient parenteral antibiotic therapy Toxic shock syndrome (TSS), 108-109,
Influenza, 165-169 (OPAT), 102-106 110-111
International Society for Infectious Transplants
Diseases (ISID), 2-3 Parenteral antibiotic therapy, 102-106 bone marrow, S56-S58
Intravitreal ganciclovir, 70-74 infections from, 222-225, S54,
Invasive candidiasis, 78-82, S7-S9, PCR. See Polymerase chain reaction S56-S58
Sll-S17,S56-S58 Peptic ulcers, 47-53 kidney, 222-225
IS1 1 IO-related sequences, 192-198 Pertussis vaccine, 6-12,143-147, organ; 222-225, S54
ISID. See International Society for 148-151 Trichosporon, S42, S43-S44
Infectious Diseases Peru Trichosporosis, S42, S43-S44
Itraconazole, S26, S49, S50, S53 cholera in, 38-40 TSS. See Toxic shock syndrome
Tuberculin, 115-116
humanT-cell lymphotropic virus type
Japanese immigrants, 75-77 Tuberculosis (TB)
I in, 75-77
Jenner, Edward, 117 bacterial vaccines for, 172-177
PFGE. See Pulsed-field gel electrophoresis HIV and, 22-27,173
Kass, Edward Harold, 1 Phage typing, 95-97 in Kigali (Rwanda), 22-27
Ketoconazole, S26, S53 Philippines, renal allograft infections in, inTaiwan, 18-21
Kidney transplants, 222-225 222-225
Kigali (Rwanda), tuberculosis in, 22-27 Pneumococcal infections, 165-169 Ulcers, 47-53
Koch, Robert K., 115-116 Poliomyelitis, 125-129 Urinary tract infection (UTI), 92-94
Urosepsis, 92-94
vaccine, 143,145,235 UTI. See Urinary tract infection
Latin America, cholera in, 38-40
Live attenuated varicella vaccine, Polyenes, S25
130-133 Polymerase chain reaction (PCR), Vaccination. See Immunization;Vaccines
Liver disease, 215-216 28-24,186-190,206-21O,S20-S23 Vaccines
Loa loa, 35-36 Prophylaxis, S47-S50, S52 bacterial, 172-177
Pulsed-field gel electrophoresis (PFGE), DTP6-12,143-147,148-151,235
Mazzotti reaction, 36 95-97,187-188 heoatitis. 226-231
Meningitis PuruIent meningitis, 179-180 pneumococcal, 167-168
acute purulent, 179- 180 rabies, 137-138
cirrhosis and, 98- 100 supply and quantity, 120- 12 1
group B meningococcal, 158- 163 Rabies tuberculosis, 172-177
Meningococcal polysaccharide vaccines in 1996,135-141 varicella, 130-133
group B, 158-163 stray dog, 136 See also Immunization;
protein conjugate, 152-156 vaccines, 137- 138 Meningococcal polysaccharide
Methicillin-resistant Staphylococcus vaccines
16s rDNA gene, 206-210
aureus (MRSA), 186-190 Vancomycin-resistant enterococci (VRE)
Renal allograft infections, 222-225 normal flora and, 63-64
Miconazole, S26
Molecular diagnosis, S20-S23 Restriction fragment length poly- rectal swab culture of, 87-91
M protein, 109-110 morphism (RFLP), 18-22,192-198 Varicella vaccine, 130- 133
MRSA. See Methicillin-resistant Retinitis, 70-74 Varicella-zoster virus
Staphylococcus aureus RFLP See Restriction fragment length Oka strain, 130-131
Mucorales, S42, S44 polymorphism wild-tvpe, 131
Mycobacterium avium, 192-198 Rheumatic fever, 108 Vibrio chblerae, 29,37-44,212-214
Mycobacterium tuberculosis, 18-21, Vibrio hollisae. 215-216
Rwanda, tuberculosis in, 22-27 VRE. See Vancomycin-resistant
22-27,98,172-177
Rwandan refugees, 199-200 enterococci
Nasal carriage, 186-190
Necrotizine fasciitis. 107- 112 Salmonella, 29 Wild-type varicella-zoster virus, 13 1
Neisseria kenirzgi~dis, 158-159,179 Salmonella typhi, 95-97 Wuchereria bancrofti, 35
Neonates, 83-86 Salvador (Brazil), diarrhea in, 28-34
Neutropenia, S2-S5, S32-S35, S52-S54 Yersinia, 206-210
Semmelweis, Ignaz, 57-58 Yersinia enterocolitica, 206-210
Nosocomial bacteremia, 182-183,
202-205 Shigella, 29
Nosocomial candidiasis, Sl, S37-S40 Socioeconomic status, 28-34 Zaire, cholera in, 41
Nosocomial urosepsis, 92-94 Somalia, 186-190 Zygomycosis, S42, S44